Evidence map›Paper›PMID 29491865›Full record

ArticleFrontiers in immunology2018

Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy.

Anicet Christel Maloupazoa Siawaya, Ofilia Mvoundza Ndjindji, Eliane Kuissi Kamgaing, Amandine Mveang-Nzoghe, Chérone Nancy Mbani Mpega, Marielle Leboueny, Roselyne Kengue Boussougou, Armel Mintsa Ndong, Paulin N Essone, Joel Fleury Djoba Siawaya

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Anicet Christel Maloupazoa SiawayaCentre Hospitalier Universitaire Mère-Enfant Fondation Jeanne Ebori (CHUMEFJE), Libreville, Gabon.
Ofilia Mvoundza NdjindjiCentre Hospitalier Universitaire Mère-Enfant Fondation Jeanne Ebori (CHUMEFJE), Libreville, Gabon.
Eliane Kuissi KamgaingDépartement de Pédiatrie, Université des Sciences de la Santé d'Owendo (USS), Owendo, Gabon.
Amandine Mveang-NzogheCentre Hospitalier Universitaire Mère-Enfant Fondation Jeanne Ebori (CHUMEFJE), Libreville, Gabon.
Chérone Nancy Mbani MpegaDépartement de Chimie, Faculté des Sciences, Université des sciences et techniques de Masuku, Franceville, Gabon.
Marielle LebouenyCentre Hospitalier Universitaire Mère-Enfant Fondation Jeanne Ebori (CHUMEFJE), Libreville, Gabon.
Roselyne Kengue BoussougouUnité de Virologie, Laboratoire National de Santé Publique à Libreville (LNSP), Libreville, Gabon.
Armel Mintsa NdongUnité de Virologie, Laboratoire National de Santé Publique à Libreville (LNSP), Libreville, Gabon.
Paulin N EssoneUnités de Recherche et de Diagnostics Spécialisés, Laboratoire National de Santé Publique à Libreville (LNSP), Libreville, Gabon.
Joel Fleury Djoba SiawayaCentre Hospitalier Universitaire Mère-Enfant Fondation Jeanne Ebori (CHUMEFJE), Libreville, Gabon.
Université des Sciences de la Santé · GALibreville Hospital · GAUniversitätsklinikum Tübingen · DEUniversité des Sciences et Techniques de Masuku · GA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogen sensing and recognition through pattern recognition receptors, and subsequent production of pro-inflammatory cytokines, is the cornerstone of the innate immune system. Despite the fact that HIV-exposed uninfected (HEU) infants are prone to serious bacterial infections, no study has focused on the functionality of their bacteria recognition system. This is the first study to investigate baseline levels of three critically important immune response molecules in this population: complement component (C)-3, toll-like receptor (TLR)-4, and C-reactive protein (CRP). We enrolled 16 HEU and 6 HIV-unexposed (HU) infants. TLR4 function was investigated by stimulating whole blood with increasing concentrations of TLR4-agonist ultrapure lipopolysaccharides. TLR4/TLR4-agonist dose response were assessed by measuring IL-6 secretion. Complement C3 and CRP were measured by photo spectrometry. Data showed no significant differences in baseline concentration of CRP between HEU and HU infants. Complement C3 was significantly higher in HEU infants than HU infants. TLR4 anergy was observed in 7 of 12 HEU infants, whereas the rest of HEU infants (

Indexed as

Complement C3C-Reactive ProteinFemaleGabonHIV-1HIV InfectionsHumansImmune ToleranceInfant, NewbornInterleukin-6LipopolysaccharidesMalePregnancyPregnancy Complications, InfectiousProspective StudiesToll-Like Receptor 4Complement C3C-Reactive ProteinIL6 protein, humanInterleukin-6LipopolysaccharidesTLR4 protein, humanToll-Like Receptor 4complement component-3C-reactive proteinHIV-1infantstoll-like receptor-4

Identifiers

PMID29491865
PMCPMC5817973
OpenAlexW2791911346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.